Hae
Aineistot 1-1 / 1
Use of preclinical and early clinical data for dose selection of a selective estrogen receptor modulator toremifene in treatment of breast cancer
(Annales Universitatis Turkuensis D 1015Turun yliopisto, 2012-06-15)
In development of human medicines, it is important to predict early and accurately enough
the disease and patient population to be treated as well as the effective and safe dose range
of the studied medicine. This is ...